At close: December 13 at 4:00:02 PM EST
After hours: 7:49:43 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-27,199.9060
-25,173.6390
-19,030.2080
-11,196.4200
-2,750.5700
Investing Cash Flow
-39.6020
-48.9460
-134.2580
-47.7180
-156.7910
Financing Cash Flow
23,144.9900
4,062.4420
35,353.3280
12,784.2120
12,507.8160
End Cash Position
8,592.5230
6,452.5890
27,612.7320
11,423.8700
9,883.7960
Capital Expenditure
-39.6020
-48.9460
-134.2580
-47.7180
-156.7910
Issuance of Capital Stock
16,730.4150
--
27,727.1940
9,408.9200
11,458.4960
Issuance of Debt
--
--
--
--
1,058.7000
Repayment of Debt
--
--
--
-27.8640
-11.8800
Repurchase of Capital Stock
--
--
--
-1.0000
--
Free Cash Flow
-27,239.5080
-25,222.5850
-19,164.4660
-11,244.1380
-2,907.3610
12/31/2020 - 9/25/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VRAX Virax Biolabs Group Limited
1.5700
-2.48%
TNXP Tonix Pharmaceuticals Holding Corp.
0.2405
+5.07%
LGVN Longeveron Inc.
1.8600
0.00%
BIOR Biora Therapeutics, Inc.
0.5597
0.00%
CDIO Cardio Diagnostics Holdings, Inc.
1.2600
+5.00%
GRI GRI Bio, Inc.
0.8000
-5.55%
CYCN Cyclerion Therapeutics, Inc.
3.4300
-3.92%
XCUR Exicure, Inc.
17.31
-1.09%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.8100
+2.26%
ENSC Ensysce Biosciences, Inc.
5.62
-8.17%